Relationship between MDR1 gene and surface markers in acute myeloid leukemia

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 749-752

  Zöchbauer, Sabine ^a   Schwarzinger, Ilse ^b   Strobl, Herbert ^c   Lechner, Klaus ^a   Pirker, Robert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute myeloid leukemia; MDR1 gene; P glycoprotein; Phenotyping; Surface markers

Indexed keywords

BLOOD GROUP ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD7 ANTIGEN; CELL SURFACE MARKER; GLYCOPROTEIN P; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL TRIAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, MDR; HUMANS; LEUKEMIA, MYELOID; MALE; P-GLYCOPROTEIN; RNA, MESSENGER;

EID: 1842329758     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sato H, Preisler H, Day R, Raza A, Larson R, Browman G, Goldberg J, Vogler R, Grunwald H, Gottlieb A, Bennett J, Gottesman M and Pastan I: MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukemia. Br J Haematol 75: 340-345, 1990.
2. Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Seherrer R, Valent P, Havelec L, Ludwig H and Lechner K: MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83: 708-712, 1991.
3. Marie JP, Zittoun R and Sikic BI: Multidrug resistance (mdr1) gene expression in adult leukemias. Correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 586-592, 1991.
4. Campos T, Guyotat D Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D and Fiere D: Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79: 473-476, 1992.
5. Gsur A, Zöchbauer S, Götzl M, Kyrle PA, Lechner K and Pirker R: MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update. Leukemia and Lymphoma 12: 91-94, 1993.
6. Zöchbauer S, Gsur A, Brunner R, Kyrle PA, Lechner K and Pirker R: P-glycoprotein expression as an unfavourable prognostic factor in acute myeloid leukemia. Leukemia 8: 974-977, 1994.
7. Pirker R, Keilhauer G, Raschack M, Lechner K and Ludwig H: Reversal of multidrug resistance in human KB cell lines by structural analogs of verapamil. Int J Cancer 45: 916-919, 1990.
8. Lehnert M: Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues. Eur J Cancer 29A: 636-638, 1993.
9. Hofmann J, Gekeler V, Ise W, Noller A, Mitterdorfer J, Hofer S, Utz I, Gotwald M, Boer R, Glossmann H and Grunicke HH: Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Biochem Pharmacol 49: 603-609, 1995.
10. Schröder J, Esteban M, Müller MR, Kasimir-Bauer S, Bamberger U, Heckel A, Seeber S and Scheulen ME: Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo. J Cancer Res Clin Oncol 122: 307-312, 1996.
11. Pirker R, Zöchbauer S, Huber H, Kupper H, Lassmann A, Gsur A, Frass M, Kiajnik G, Knöbl P and Lechner K: Dexverapamil as resistance modifier in acute myeloid leukemia. J Cancer Res Clin Oncol 121 (suppl. 3): R21-24, 1996.
12. Bettelheim P, Paietta E, Majdic O, Gadner H, Schwarzmeier J and Knapp W: Expression of a myeloid marker on TdT-positive acute lymphocytic leukemic cells: Evidence by double-fluorescence staining. Blood 60: 1392-1396, 1982.
13. Benedetto P, Mertelsmann R, Szatrowski TH, AndreeffM, Gee T, Arlin Z, Kempin S and Clarkson B: Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. J Clin Oncol 4:489-495, 1986.
14. Schwarzinger I, Valent P, Köller U, Marosi C, Schneider B, Haas O, Knapp W, Lechner K and Bettelheim P: Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. J Clin Oncol 8: 423-430, 1990.
15. Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S and Civin CI: Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My 10). Br J Haematol 76: 3411-347, 1990.
16. Gucalp R, Paietta E, Weinberg V, Papenhausen P, Dutcher JP and Wiernik PH: Terminal transferase expression in acute myeloid leukemia: biology and prognosis. Br J Haematol 77: 48-54, 1991.
17. Solary E, Casasnovas RO, Campos L, Bone MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N and the Groupe d' Ètude Immunologique des Leucemies (GEIL): Surface markers in adult acute myeloblastic leukemia: Correlation of CD19+, CD34+ and CD14+/DR-phenotypes with shorter survival. Leukemia 6: 393-399, 1992.
18. Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A and Schiffer CA: The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 6: 1203-1209, 1992.
19. Boekhorst P, Leeuw K, Schoester M, Wittebol S, Nooter K, Hagemeijer A, Löwenberg B and Sonneveld P: Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 82: 3157-3162, 1993.
20. Miwa H, Kita K, Nishii K, Morita N, Takakura N, Ohishi K, Mahmud N, Kageyama S, Fukumoto M and Shirakawa S: Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoplastic leukemia. Blood 82: 3445-3451, 1993.
21. Wood P, Burgess R, MacGregor A and Liu Yin JA: P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. Br J Haematol 87: 509-514, 1994.
22. Lamy T, Goasguen JE, Mordelet E, Grulois I, Dauriac C, Drenou B, Chaperon J, Fauchet R and Le Prise PY: P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML). Leukemia 8: 1879-1883, 1994.
23. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A and Papa G: Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 8: 388-394, 1994.
24. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.